These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37245960)

  • 1. Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin.
    Kitamoto T; Accili D
    Endocr J; 2023 Sep; 70(9):851-866. PubMed ID: 37245960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes.
    Guerra S; Gastaldelli A
    Curr Opin Pharmacol; 2020 Dec; 55():165-174. PubMed ID: 33278735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver and insulin resistance: New wine in old bottle!!!
    Patel BM; Goyal RK
    Eur J Pharmacol; 2019 Nov; 862():172657. PubMed ID: 31499040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in obesity and type 2 diabetes.
    Bonadonna RC; De Fronzo RA
    Diabete Metab; 1991 May; 17(1 Pt 2):112-35. PubMed ID: 1936466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered metabolism in diabetes: have we underemphasized the fat component?
    McGarry JD
    J Cell Biochem; 1994; 55 Suppl():29-38. PubMed ID: 7929616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangduqing Granules Attenuate Insulin Resistance and Abnormal Lipid Metabolism through the Coordinated Regulation of PPAR
    Zhang Q; Huang Y; Li X; Liu H; He B; Wang B; Ma Y; Zhou X; Liu Y; Wu S
    J Diabetes Res; 2019; 2019():7403978. PubMed ID: 31019978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
    Mokashi P; Bhatt LK; Khanna A; Pandita N
    Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia.
    Haeusler RA; Han S; Accili D
    J Biol Chem; 2010 Aug; 285(35):26861-26868. PubMed ID: 20573950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
    Otero YF; Stafford JM; McGuinness OP
    J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM.
    Colosimo S; Mitra SK; Chaudhury T; Marchesini G
    Diabetes Res Clin Pract; 2023 Dec; 206():111016. PubMed ID: 37979728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin signaling gene expression in insulin sensitive tissues between cats and dogs.
    Mori A; Lee P; Takemitsu H; Sako T; Arai T
    Vet Res Commun; 2009 Mar; 33(3):211-26. PubMed ID: 19043794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Regulation of Hepatic Metabolism by Insulin.
    Titchenell PM; Lazar MA; Birnbaum MJ
    Trends Endocrinol Metab; 2017 Jul; 28(7):497-505. PubMed ID: 28416361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues.
    Lin HV; Ren H; Samuel VT; Lee HY; Lu TY; Shulman GI; Accili D
    Diabetes; 2011 Mar; 60(3):700-9. PubMed ID: 21266328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxO1, the transcriptional chief of staff of energy metabolism.
    Kousteni S
    Bone; 2012 Feb; 50(2):437-43. PubMed ID: 21816244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
    Dong Y; Gao G; Fan H; Li S; Li X; Liu W
    PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.